Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Argus Health
Colorcon
AstraZeneca
Medtronic
Express Scripts
Fuji
Cerilliant
Queensland Health

Generated: July 20, 2018

DrugPatentWatch Database Preview

HALCION Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Halcion, and what generic alternatives are available?

Halcion is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in HALCION is triazolam. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the triazolam profile page.
Drug patent expirations by year for HALCION
Pharmacology for HALCION
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for HALCION
Synonyms for HALCION
12-chloro-9-(2-chlorophenyl)-3-methyl-2,4,5,8-tetraazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
12-CHLORO-9-(2-CHLOROPHENYL)-3-METHYL-2,4,5,8-TETRAAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(10),3,5,8,11,13-HEXAENE
1HM943223R
28911-01-5
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-
4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(o-chlorophenyl)-1-methyl-
8-chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo-[4,3-a][1,4] benzodiazepine
8-chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepine
8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-6-[2-chlorophenyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
911T015
AC1L1KLZ
Alti-Triazolam
Apo Triazo
Apo-Triazo
Apo-Triazo (TN)
Apotex Brand of Triazolam
BDBM50001765
BRN 1226643
C-55038
C17H12Cl2N4
CAS-28911-01-5
CCRIS 1932
CHEBI:9674
CHEMBL646
Clorazolam
CS-2934
D00387
D0U3LS
DB00897
DEA No. 2887
DSSTox_CID_26763
DSSTox_GSID_46763
DSSTox_RID_81886
DTXSID6046763
EINECS 249-307-3
FT-0675395
Gen Triazolam
Gen-Triazolam
Genpharm Brand of Triazolam
Gerard Brand of Triazolam
GTPL7313
Halcion (TN)
Halcion (triazolam)
HE004850
HSDB 6759
HY-B0694
Hypam
Hypam (TN)
Hypnostat
JOFWLTCLBGQGBO-UHFFFAOYSA-N
L000796
LS-156323
MFCD00079623
MLS003899243
NCGC00168258-01
Novidorm
Novo-Triolam
Novodorm
Pfizer Brand of Triazolam
PL043946
SCHEMBL29228
SMR000058837
Songar
SR-01000937604
SR-01000937604-2
TGAR01H
Tox21_112617
triazolam
Triazolam (JAN/USP/INN)
Triazolam [USAN:BAN:INN:JAN]
Triazolam 0.1 mg/ml in Methanol
Triazolam 1.0 mg/ml in Methanol
triazolam 100 ug per ml in methanol
Triazolam Pfizer Brand
Triazolam, European Pharmacopoeia (EP) Reference Standard
Triazolamum
Triazolamum [INN-Latin]
Trilam
Trilam (TN)
U 33,030
U 33030
U-33,030
U-33030
U33,030
U33030
UNII-1HM943223R
ZB000504
ZINC2212

US Patents and Regulatory Information for HALCION

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-003 Apr 26, 1985 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for HALCION

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-003 Apr 26, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Boehringer Ingelheim
Fuji
Accenture
Cerilliant
Teva
Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.